Skip to main content
永顺生物 logo

永顺生物 — Investor Relations & Filings

Ticker · 920729 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 388 across all filing types
Latest filing 2022-01-19 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920729

About 永顺生物

https://www.winsun-gd.com/

Guangdong Winsun Bio-Pharmaceutical Co., Ltd. is a specialized enterprise focused on the research, development, production, and distribution of veterinary biological products. The company primarily develops vaccines for livestock and poultry, with a significant emphasis on swine and avian health. Its product portfolio includes live and inactivated vaccines targeting major diseases such as classical swine fever, porcine reproductive and respiratory syndrome (PRRS), and avian influenza. Winsun Bio-Pharmaceutical leverages advanced biotechnology to provide comprehensive animal disease prevention and control solutions. The company maintains a strong focus on technological innovation and quality management, operating multiple GMP-certified production lines to ensure the efficacy and safety of its biological preparations. Its research initiatives often involve collaborations with academic institutions to advance veterinary medicine and support the animal husbandry sector.

Recent filings

Filing Released Lang Actions
第四届监事会第七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Guangdong Yongshun Biopharmaceutical Co., Ltd. It details the meeting date, attendance, agenda items, voting results, and references to related announcements on the Beijing Stock Exchange disclosure platform. The content focuses on board meeting decisions and procedural compliance, without financial statements or detailed financial analysis. It is not an annual or interim report, earnings release, or audit report. It is not a proxy solicitation or voting results announcement for shareholders but rather a board/committee meeting resolution announcement. Given the nature of the document as a Supervisory Board meeting resolution announcement, it fits best under Board/Management Information (MANG). The document length is short and does not contain financial data, so it is not a full report but a meeting resolution announcement. Therefore, the classification is MANG with high confidence.
2022-01-19 Chinese
内幕信息管理制度
Governance Information Classification · 95% confidence The document is a detailed internal regulation titled "Insider Information Management System" issued by Guangdong Yongshun Biopharmaceutical Co., Ltd. It outlines the company's policies and procedures for managing insider information, including definitions, responsibilities, confidentiality obligations, and legal compliance. The document is dated January 20, 2022, and includes references to relevant laws and regulatory bodies such as the China Securities Regulatory Commission and the Beijing Stock Exchange. It is not a financial report, earnings release, or announcement of voting results. It is also not a brief announcement or a certification. The content focuses on governance and compliance related to insider information management, which fits best under Governance Information (CGR). The document length (6665 characters) and detailed content support this classification with high confidence.
2022-01-19 Chinese
股东大会议事规则
Governance Information Classification · 95% confidence The document is titled as the "Rules of Procedure for the Shareholders' General Meeting" of Guangdong Yongshun Biopharmaceutical Co., Ltd. It details the governance, procedures, rights, and responsibilities related to the shareholders' meetings, including the convening, proposal submission, voting, and resolutions of the shareholders' meetings. It does not contain financial statements, audit opinions, or earnings data. It is a governance-related document focused on internal rules and procedures for shareholder meetings. Therefore, it fits best under Governance Information (CGR). The document length is substantial and contains detailed governance rules, not just an announcement or summary, so it is not a Regulatory Filing or Report Publication Announcement.
2022-01-19 Chinese
关于预计 2022 年日常性关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the expected related party transactions for the year 2022 by Guangdong Yongshun Biopharmaceutical Co., Ltd. It includes detailed descriptions of the nature, amounts, and reasons for these transactions, as well as the approval and opinions from the board and independent directors. The document is a formal disclosure of anticipated related party transactions, which is a regulatory announcement rather than a full financial report or audit. It does not contain comprehensive financial statements or detailed financial analysis. The document length is 4443 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements and compliance disclosures that do not fit other specific categories.
2022-01-19 Chinese
关于召开 2022 年第一次临时股东大会通知公告（提供网络投票）
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice announcing the convening of the 2022 first extraordinary general meeting of shareholders (临时股东大会) for Guangdong Yongshun Biopharmaceutical Co., Ltd. It details the meeting date, voting methods, agenda items to be discussed, registration methods, and other procedural information. It does not contain actual financial statements or results, nor is it a transcript or presentation. It is not a report but an announcement of a shareholders meeting. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2022-01-19 Chinese
网络投票制度实施细则
Governance Information Classification · 95% confidence The document is titled as an implementation detail of the company's network voting system for shareholder meetings, specifically for the company's board and shareholder voting procedures. It includes detailed rules about voting mechanisms, preparation, and counting of votes for shareholder meetings. There is no financial data, no earnings or annual report content, no audit information, no management changes, no legal proceedings, no capital updates, and no voting results announcement. The document is a regulatory announcement about the internal procedures for shareholder voting, which aligns with governance-related information. However, it is not a governance report detailing board structure or governance practices but rather a procedural announcement about voting system implementation. Given the detailed procedural nature and the focus on shareholder meeting voting rules, the best fit is Governance Information (CGR). The document is 2506 characters, which is not a brief announcement but a substantive procedural document, so it is not a simple announcement (RPA).
2022-01-19 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.